D-1384-2012 Class III Terminated

Recalled by Teva Pharmaceuticals USA, Inc. — Sellersville, PA

FDA drug recall D-1384-2012 was initiated by Teva Pharmaceuticals USA, Inc. on Apr 23, 2012 and is designated Class III. Reason for recall: Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets. The recall status is terminated (terminated Apr 23, 2013). Affected quantity: 40,750 Dispensers.

Recall details

Product Type
Drugs
Report Date
Jun 27, 2012
Initiation Date
Apr 23, 2012
Termination Date
Apr 23, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
40,750 Dispensers

Product description

Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

Reason for recall

Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

Distribution pattern

Nationwide

Code information

Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1384-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1384-2012. Report a data issue: hello@regdatalab.com.